Background/Aims: People who inject drugs (PWID) experience high incarceration rates, and previous incarceration is associated with elevated hepatitis C virus (HCV) transmission risk. We evaluate the contribution of incarceration to HCV transmission amongst PWID, and the impact of prison-related prevention interventions, including scaling-up direct-acting antivirals (DAAs) in prison.Design: Dynamic mathematical modelling of incarceration and HCV transmission, using approximate Bayesian computation for model calibration.Setting: Scotland; where national survey data indicates lower HCV incidence in prison than the community (4.3 vs 7.3 per 100py), but a 2.3-fold elevated transmission risk amongst recently released (16 weeks) could reduce incid...
Background: The advent of novel, highly efficacious, and well tolerated hepatitis C virus (HCV) ther...
Prisons are a key demographic in the drive to eradicate hepatitis C virus (HCV) as a major public he...
Prisoners are a priority group for hepatitis C (HCV) treatment. Although treatment durations will be...
Background/Aims: People who inject drugs (PWID) experience high incarceration rates, and previous in...
Background and Aims: To reduce hepatitis C virus (HCV) transmission among people who inject drugs (P...
BACKGROUND: In England and Wales where less than 1% of the population are Injecting drug users (IDUs...
Background: in England and Wales where less than 1% of the population are Injecting drug users (IDUs...
HCV is mainly transmitted between people who inject drugs in developed countries. In this population...
BACKGROUND: Hepatitis C virus (HCV) infection is common among prisoners, particularly those with a h...
Background: Hepatitis C virus (HCV) transmission in the European Union, European Economic Area and U...
Background. Hepatitis C is a curable and preventable disease. People who inject drugs (PWID) and pri...
Background: Hepatitis C Virus (HCV) infection is a global epidemic with an estimated 71 million peop...
Hepatitis C virus (HCV) infection remains a major health problem despite the availability of highly...
Aims To estimate hepatitis C virus (HCV) incidence and HCV risk among Scottish prisoners. Design Nat...
To gauge the incidence of hepatitis C virus (HCV) infection and associated risk factors among inmate...
Background: The advent of novel, highly efficacious, and well tolerated hepatitis C virus (HCV) ther...
Prisons are a key demographic in the drive to eradicate hepatitis C virus (HCV) as a major public he...
Prisoners are a priority group for hepatitis C (HCV) treatment. Although treatment durations will be...
Background/Aims: People who inject drugs (PWID) experience high incarceration rates, and previous in...
Background and Aims: To reduce hepatitis C virus (HCV) transmission among people who inject drugs (P...
BACKGROUND: In England and Wales where less than 1% of the population are Injecting drug users (IDUs...
Background: in England and Wales where less than 1% of the population are Injecting drug users (IDUs...
HCV is mainly transmitted between people who inject drugs in developed countries. In this population...
BACKGROUND: Hepatitis C virus (HCV) infection is common among prisoners, particularly those with a h...
Background: Hepatitis C virus (HCV) transmission in the European Union, European Economic Area and U...
Background. Hepatitis C is a curable and preventable disease. People who inject drugs (PWID) and pri...
Background: Hepatitis C Virus (HCV) infection is a global epidemic with an estimated 71 million peop...
Hepatitis C virus (HCV) infection remains a major health problem despite the availability of highly...
Aims To estimate hepatitis C virus (HCV) incidence and HCV risk among Scottish prisoners. Design Nat...
To gauge the incidence of hepatitis C virus (HCV) infection and associated risk factors among inmate...
Background: The advent of novel, highly efficacious, and well tolerated hepatitis C virus (HCV) ther...
Prisons are a key demographic in the drive to eradicate hepatitis C virus (HCV) as a major public he...
Prisoners are a priority group for hepatitis C (HCV) treatment. Although treatment durations will be...